Status:
COMPLETED
Vitamin D Supplementation on in Major Orthopedic Surgery
Lead Sponsor:
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Conditions:
Hypovitaminosis D
Cardiovascular Diseases
Eligibility:
All Genders
55-85 years
Phase:
PHASE4
Brief Summary
Prospective, monocentric study in open, aimed at evaluating the effects of supplementation with calcifediol on left ventricular function parameters in cardiopathic subjects undergoing major orthopedic...
Detailed Description
Population of the study: 47 cardiopathic patients with hypovitaminosis D supplemented with calcifediol to reach vitamin D levels\> 30 ng / ml within 6 months. The purpose of this study is to evaluate ...
Eligibility Criteria
Inclusion
- Age: \> or equal to 55 years, \< or equal to 85 years
- cardiopathic patients (including hypertension) who must undergo major orthopedic surgery at our site
- patients with diagnosis: hypovitaminosis d
Exclusion
- presence of neoplasm
- endocrinological pathologies excluding diabetes mellitus
- advanced chronic renal failure (GFR \< 35 ml/min)
- pregnant women
- impossibility to participate to the rehabilitation protocol or to perform the established controls
Key Trial Info
Start Date :
January 16 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 16 2018
Estimated Enrollment :
74 Patients enrolled
Trial Details
Trial ID
NCT03403933
Start Date
January 16 2017
End Date
July 16 2018
Last Update
May 9 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Istituto Ortopedico Galeazzi
Milan, Italy